SPOTLIGHT -
Blepharoptosis in korean patients: Old age and high BMI are risks
Cutoff age for evaluation: 66 years
Novel therapeutic approach offers nonsurgical option for acquired blepharoptosis
Use of a drug to correct the eyelid position could eliminate the complications associated with surgery.
Blepharoptosis: Unraveling this not-so-simple disorder
Perhaps the most important consideration is understanding the neuromuscular pathway that retracts and protracts the eyelid.
Raising awareness: Dissemination of information to help patients get ahead of glaucoma
Mobile glaucoma apps may play limited role in awareness, education
'Nepafenac may reduce macular volume
Use of nepafenac may decrease macular volume more rapidly after surgery to repair epiretinal membranes.
Olopatadine: Once-daily dosing benefit
Olopatadine hydrochloride ophthalmic solution 0.2%, a combination mast cell stabilizer and antihistamine, effectively relieves the itching associated with allergic conjunctivitis with once-daily dosing.
